Using novel primary human culture models, how would you propose to investigate molecular mechanisms underlying myeloid/stromal interaction in solid tumors with the goal of identifying actionable translational biomarkers?

Jillian Prendergast
Reniqua House

Jillian Prendergast, Reniqua House
Oncology Translational Science

Using suitable model systems, how would you propose to elucidate and validate the putative role of GluN3A in symptoms related to mental illness?

Moritz von Heimendahl

Moritz von Heimendahl
Principal Scientist
Neuroscience & Mental Health Discovery Research

Latest active call

double helix
0

Discovery of human myeloid/stromal biomarkers

Collaborate with us

Hear from our collaborators

opnMe facilitated an efficient research partnership with Boehringer Ingelheim, accelerating the discovery of bioactive peptides. opnMe enabled us to combine expertise and resources, therefore leveraging the strengths of both organizations to achieve innovative outcomes.

CMO, PXBioVisioN GmbH, Hannover

With the help of opnMe, we teamed up with Boehringer Ingelheim to develop a human-in-the-loop AI solution for pre-clinical research. We’re excited to see the tool in active use, having a measurable positive impact on the daily work of the scientists and increasing the safety of drug discovery.

CTO, Merantix Momentum GmbH, Berlin

I found the opnMe portal very easy to navigate and use. The application process is straightforward; this can be achieved in one afternoon. The time from submission to decision is one of the fastest turnarounds I have had, and this aspect makes a real difference in the momentum of pursuing a scientific idea.

Associate Professor, University College London

opnMe's expert guidance was pivotal in forging our research collaboration with Boehringer Ingelheim. Their initiative seamlessly bridged the gap between academic and industry research, uniting foundational biomedical science with application-oriented translational animal health research.

Associate Professor, City University of Hong Kong

opnMe represents a great concept of open science in two ways: It allows Boehringer to stimulate research at the forefront of scientific discovery within a well-defined disease area and it allows academics to excel by approaching Boehringer Ingelheim with proactive, innovative ideas.

Vice President Research, ETH Zurich

As an academic postdoc, opnMe provided me with the opportunity to apply my skills in a "semi-industry" setting. Collaborating with Boehringer Ingelheim’s experts on pharmacologically relevant questions in neuroscience was particularly exciting, as it aligns with my deep passion for the field.

Senior Research Fellow, Temasek Life Sciences Laboratory, Singapore

It has been a pleasure for me to participate in opnMe. In addition to providing funding for our research project, it has given my lab an opportunity to collaborate with excellent people at Boehringer Ingelheim, generated some exciting results, and taught us new things about brain circuitry.

Senior Investigator, Temasek Life Sciences Laboratory, Singapore